Psychedelic Medicine Podcast: Managing risk in patients seeking psilocybin therapy

Thanks to Dr. Lynn Marie Morski for having me on the Psychedelic Medicine Podcast. In our discussion, we review some key medical considerations when it comes to the use of psilocybin therapy:

  • The emerging medical indications for psilocybin therapy (e.g., depression, anxiety…)

  • How the research into psilocybin has developed in the past few years

  • The pharmacokinetics of psilocybin

  • Medication interactions with psilocybin, especially antidepressants

  • Risks of serotonin syndrome

  • Absolute vs relative contraindications

  • Psilocybin’s cardiac effects

I hope you find this information useful—and most of all, I want to emphasize how important it is for clinicians and patients alike to be aware of the potential medical and psychological risks of psilocybin and other psychedelics. Especially amidst so much excitement coming from groundbreaking studies and legislature, there is still very much a need to be cautious in our approach. Enjoy listening!

 
Previous
Previous

Vice: Couples are doing MDMA and ketamine therapy to save their relationships

Next
Next

Salt Lake Tribune: Utah failed to legalize psilocybin—but local research, and an underground scene, is booming